Arax Advisory Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
Arax Advisory Partners's AUPH Position: Q2 2026 in Review
Arax Advisory Partners increased its Aurinia Pharmaceuticals (AUPH) stake by 2,368% in Q2 2026, buying an estimated $210K and bringing the position to 13,674 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.
Arax Advisory Partners first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Arax Advisory Partners held 13,674 shares of Aurinia Pharmaceuticals worth $232K as of Q2 2026.
- Arax Advisory Partners bought 13,120 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $210K.
- Aurinia Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2148 holding.
- Arax Advisory Partners first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.